Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial - Authors' reply.
Peto L. et al, (2024), Lancet (London, England), 403, 1339 - 1340
Nipah Virus Therapeutics: A Systematic Review to Support Prioritisation for Clinical Trials
Chan XHS. et al, (2024)
Mpox: The alarm went off. Have we gone back to sleep?
Olliaro P. et al, (2024), PLOS Neglected Tropical Diseases, 18, e0011871 - e0011871
Nipah virus disease: what can we do to improve patient care?
Hassan MZ. et al, (2024), Lancet Infectious Diseases
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
Faust SN. et al, (2024), The Lancet Child & Adolescent Health
Community involvement in an outbreak - One year on for mpox.
Cheyne A. et al, (2023), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Abani O. et al, (2023), The Lancet Diabetes & Endocrinology, 11, 905 - 914
Evaluation of pragmatic oxygenation measurement as a proxy for Covid-19 severity
Swets MC. et al, (2023), Nature Communications, 14
Methylprednisolone, intravenous immunoglobulin, tocilizimab or anakinra for children with Paediatric Inflammatory Multisystem Syndrome temporally associated with SARS CoV-2 (PIMS-TS, MIS-C) – report from a randomised, controlled, open-label, platform trial
Landray M. et al, (2023), Lancet Child and Adolescent Health
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Peto L. et al, (2023), Nature Communications
The burden and dynamics of hospital-acquired SARS-CoV-2 in England
Cooper BS. et al, (2023), Nature, 623, 132 - 138
A multi-country analysis of COVID-19 hospitalizations by vaccination status.
Gonçalves BP. et al, (2023), Med (New York, N.Y.), 4, 797 - 812.e2
Author Correction: GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19.
Pairo-Castineira E. et al, (2023), Nature, 619
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19.
Pairo-Castineira E. et al, (2023), Nature, 617, 764 - 768
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Abani O. et al, (2023), The Lancet, 401, 1499 - 1507
Seroepidemiology of Lassa virus in pregnant women in Southern Nigeria: A prospective hospital-based cohort study.
Kayem ND. et al, (2023), PLoS neglected tropical diseases, 17
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19
Kartsonaki C. et al, (2023), International Journal of Epidemiology, 52, 355 - 376